Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Vitamin D receptor and Alzheimer's disease: a genetic and functional study.

Wang L, Hara K, Van Baaren JM, Price JC, Beecham GW, Gallins PJ, Whitehead PL, Wang G, Lu C, Slifer MA, Züchner S, Martin ER, Mash D, Haines JL, Pericak-Vance MA, Gilbert JR.

Neurobiol Aging. 2012 Aug;33(8):1844.e1-9. doi: 10.1016/j.neurobiolaging.2011.12.038. Epub 2012 Feb 4.

PMID:
22306846
2.

Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.

Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Hollis BW, Giovannucci E.

Prostate. 2007 Jun 15;67(9):911-23.

PMID:
17440943
3.

Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly.

Fang Y, van Meurs JB, Bergink AP, Hofman A, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG.

J Bone Miner Res. 2003 Sep;18(9):1632-41.

4.

Association of vitamin D receptor gene variants, adiposity and colon cancer.

Ochs-Balcom HM, Cicek MS, Thompson CL, Tucker TC, Elston RC, J Plummer S, Casey G, Li L.

Carcinogenesis. 2008 Sep;29(9):1788-93. doi: 10.1093/carcin/bgn166. Epub 2008 Jul 14.

5.

The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene.

Arai H, Miyamoto KI, Yoshida M, Yamamoto H, Taketani Y, Morita K, Kubota M, Yoshida S, Ikeda M, Watabe F, Kanemasa Y, Takeda E.

J Bone Miner Res. 2001 Jul;16(7):1256-64.

6.

Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patients.

Iqbal Mu, Khan TA, Maqbool SA.

PLoS One. 2015 Mar 23;10(3):e0122657. doi: 10.1371/journal.pone.0122657. eCollection 2015.

7.

Vitamin D status and the Cdx-2 polymorphism of the vitamin D receptor gene are determining factors of bone mineral density in young healthy postmenopausal women.

Casado-Díaz A, Cuenca-Acevedo R, Navarro-Valverde C, Díaz-Molina C, Caballero-Villarraso J, Santiago-Mora R, Dorado G, Quesada-Gómez JM.

J Steroid Biochem Mol Biol. 2013 Jul;136:187-9. doi: 10.1016/j.jsbmb.2012.09.026. Epub 2012 Sep 28. Review.

PMID:
23026509
8.

Association between vitamin D receptor gene polymorphism and Alzheimer's disease.

Gezen-Ak D, Dursun E, Ertan T, Hanağasi H, Gürvit H, Emre M, Eker E, Oztürk M, Engin F, Yilmazer S.

Tohoku J Exp Med. 2007 Jul;212(3):275-82.

9.

Association of polymorphisms in the vitamin D receptor promoter with idiopathic short stature.

Choi SK, Park MS, Song JK, Yoon KS, Yoon KL, Shim KS.

J Korean Med Sci. 2013 Sep;28(9):1329-33. doi: 10.3346/jkms.2013.28.9.1329. Epub 2013 Aug 28.

10.

Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.

Pulito C, Terrenato I, Di Benedetto A, Korita E, Goeman F, Sacconi A, Biagioni F, Blandino G, Strano S, Muti P, Mottolese M, Falvo E.

PLoS One. 2015 Apr 7;10(4):e0124894. doi: 10.1371/journal.pone.0124894. eCollection 2015.

11.

The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine.

Yamamoto H, Miyamoto K, Li B, Taketani Y, Kitano M, Inoue Y, Morita K, Pike JW, Takeda E.

J Bone Miner Res. 1999 Feb;14(2):240-7.

12.

Association of VDR-gene variants with factors related to the metabolic syndrome, type 2 diabetes and vitamin D deficiency.

Al-Daghri NM, Al-Attas OS, Alkharfy KM, Khan N, Mohammed AK, Vinodson B, Ansari MG, Alenad A, Alokail MS.

Gene. 2014 Jun 1;542(2):129-33. doi: 10.1016/j.gene.2014.03.044. Epub 2014 Mar 25.

PMID:
24680778
13.

Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona.

Ogbah Z, Visa L, Badenas C, Ríos J, Puig-Butille JA, Bonifaci N, Guino E, Augé JM, Kolm I, Carrera C, Pujana MÁ, Malvehy J, Puig S.

BMC Med Genet. 2013 Feb 16;14:26. doi: 10.1186/1471-2350-14-26.

14.

Vitamin D receptor gene as a candidate gene for Parkinson disease.

Butler MW, Burt A, Edwards TL, Zuchner S, Scott WK, Martin ER, Vance JM, Wang L.

Ann Hum Genet. 2011 Mar;75(2):201-10. doi: 10.1111/j.1469-1809.2010.00631.x.

15.

Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction.

Dickinson JL, Perera DI, van der Mei AF, Ponsonby AL, Polanowski AM, Thomson RJ, Taylor BV, McKay JD, Stankovich J, Dwyer T.

Mult Scler. 2009 May;15(5):563-70. doi: 10.1177/1352458509102459. Epub 2009 Apr 21.

PMID:
19383647
16.

Vitamin D status and vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Egyptian children.

Abd-Allah SH, Pasha HF, Hagrass HA, Alghobashy AA.

Gene. 2014 Feb 25;536(2):430-4. doi: 10.1016/j.gene.2013.12.032. Epub 2013 Dec 23.

PMID:
24370753
17.

Effects of vitamin D receptor gene polymorphisms on susceptibility to disease and bone mineral density in Turkish patients with type 1 diabetes mellitus.

Kocabaş A, Karagüzel G, Imir N, Yavuzer U, Akçurin S.

J Pediatr Endocrinol Metab. 2010 Dec;23(12):1289-97.

PMID:
21714463
18.

Vitamin D-gene interactions in multiple sclerosis.

Berlanga-Taylor AJ, Disanto G, Ebers GC, Ramagopalan SV.

J Neurol Sci. 2011 Dec 15;311(1-2):32-6. doi: 10.1016/j.jns.2011.08.041. Epub 2011 Oct 13. Review.

PMID:
22000399
19.

Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.

Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, Chao MJ, Morahan J, Morrison KM, Sadovnick AD, Ebers GC.

J Neurol Sci. 2011 Jun 15;305(1-2):116-20. doi: 10.1016/j.jns.2011.02.032. Epub 2011 Mar 26.

PMID:
21440908
20.

Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.

Holick CN, Stanford JL, Kwon EM, Ostrander EA, Nejentsev S, Peters U.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1990-9.

Supplemental Content

Support Center